Navigation Links
New discovery proves cause of weight problems in Huntington's disease
Date:4/6/2011

The study, which has been published in the scientific journal Cell Metabolism, shows significant changes in the brain's hormone control centre, the hypothalamus. In a series of experiments on mice, which had the mutated Huntington's protein injected into this area of their brains, the animals soon demonstrated a reduced ability to regulate their metabolism.

"With the selectively produced mutated protein, we saw immediate changes; the mice started to eat more and became very fat. We have now been able to prove that there is a causal relationship between this mutated protein in the hypothalamus and weight gain. The changes we see in the mice's brains are similar to those we have previously observed in the brains of Huntington's patients", says doctor and researcher sa Petersn at Lund University.

The effects of the mutated Huntington's protein disable the normal control of blood sugar levels in the body. It is probable that a resistance to insulin is developed, which makes some nerve cells deaf to important signals. This stops the complex metabolic system working.

The research group has previously shown that the pathological changes in the hypothalamus begin up to ten years before the movement problems are seen. This means that new treatments targeted at the small communications control centre, the hypothalamus, could provide relief to Huntington's patients at a much earlier stage.

One of the most promising treatments that are currently being researched aims to 'turn off' the mutated Huntington's gene. The research group in Lund has successfully tested the method on mice, with the result that they stopped developing irregularities in their metabolism.

"Our idea is to turn off the mutated gene in the hypothalamus. The problem is that we don't want to turn off the normal Huntingtin gene, which still has an important function. We now hope to be able to refine our method and focus specifically on the mutated Huntingtin", says sa Petersn.

The newly discovered changes in the hypothalamus in Huntington's disease are a growing research field. The targets for new treatments are non-motor symptoms such as weight problems, sleeping problems and depression.


'/>"/>

Contact: sa Petersen
Asa.Petersen@med.lu.se
46-709-422-930
Lund University
Source:Eurekalert

Related medicine news :

1. UCSF Enters Drug Discovery Agreement with Genentech
2. UCSF enters drug discovery agreement with Genentech
3. New discovery: Plaice are spotted (on the inside)
4. SeqWright Advances Genomic Discovery With Isilon IQ
5. Effective prostate cancer treatment discovery
6. Co-Creator of Six Sigma Unveils “The Great Discovery” ... the 4th Generation of Six Sigma
7. U discovery gives insight into brain replay process
8. Discovery of cellular switch may provide new means of triggering cell death, treating disease
9. Discovery May Lead to Better Multiple Sclerosis Treatments
10. Astrogenetix Narrows in on MRSA Virulence Onboard Discovery
11. TGen Drug Development partners with Horizon Discovery for integrated personalized medicine service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... NJ (PRWEB) , ... December 08, 2016 , ... CURE ... cancer centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts to ... making the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... ... 08, 2016 , ... Today’s patients are encouraged to be ... SIGVARIS has created a new line of anti-embolism stockings to help prevent a ... benefits of graduated compression when transitioning from recovery to early rehabilitation. , The ...
(Date:12/8/2016)... ... 08, 2016 , ... The Dan Carlisle Agency, an Alabama-owned ... is announcing the launch of a charity drive to raise support and awareness ... and children in Birmingham has grown steadily since the 1980’s, and the Pathways ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... DUBLIN , Dec 8, 2016 Research and Markets ... Report" report to their offering. ... This report analyzes the worldwide markets for ... US, Canada , Japan , ... , and Rest of World. Annual estimates and forecasts are provided ...
(Date:12/8/2016)... , Dec. 8, 2016   TriNetX , ... Nationwide Children,s Hospital signed a membership agreement ... the development of new cures. The ... over 57 million patients globally, biopharmaceutical companies and ... to improve protocol design, site selection, patient recruitment, ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
Breaking Medicine Technology: